NCT00249353View on ClinicalTrials.gov

An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

October 31, 2002

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG

methylphenidate hydrochloride

All Listed Sponsors

lead

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

NCT00249353 - An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder | Biotech Hunter | Biotech Hunter